glp 1 liquid drops side effects America's Poison Centers GI Adverse Effects of Glucagon-Like

Providing access to proven GLP-1 medications could benefit health outcomes for a wide group of Americans and reduce the strain on the healthcare system associated with treating diabetes and related conditions

Krieger JP, et al

Clinicians often debate the principal pathogenic mechanisms, but no unifying theory has yet emerged

Is weight loss harmful for skeletal health in Obese older adults

The S&P 500's 3 Best-Performing Stocks So Far in 2026 Last quarter, the company submitted its drug orforglipron, a new GLP-1 agonist, for obesity treatment in the United States and more than three dozen additional countries, with an expected domestic launch by mid-2026